Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells

Medicine and Dentistry

• Neoplasm 100%
• Prostate Cancer 100%
• Stroma 100%
• Tumor Model 100%
• Stromal Cell 100%
• In Vitro 54%
• Cancer Cell 27%
• Cancer Growth 27%
• Prostate Specific Antigen 27%
• Prostate Tumor 27%
• Osteocalcin 27%
• Promoter Region 18%
• Tumor Progression 18%
• Herpes Simplex Virus 18%
• Osteosarcoma 18%
• Cell Compartment 18%
• Transgene 18%
• Thymidine Kinase 18%
• Ganciclovir 18%
• Malignant Neoplasm 9%
• Tumor Cell 9%
• Distant Metastasis 9%
• Epithelial Cell 9%
• Bone Metastasis 9%
• Epithelial Cell Line 9%
• Gene Therapy 9%
• Cancer Model 9%
• Cell Protein 9%
• Bone Marrow Stromal Cell 9%
• N (4 Methoxyphenylacetyl)dehydroalanine 9%
• Growth Stimulation 9%
• Stromal Cell Line 9%
• Androgen 9%
• Luciferase 9%
• Prodrug 9%
• Aciclovir 9%

Immunology and Microbiology

• Prostate 100%
• Stroma 100%
• Cancer Cell 71%
• Mouse 57%
• Prostate Specific Antigen 42%
• Cell Growth 42%
• Promoter Region 28%
• Coculture 28%
• Tumor Cell 28%
• Herpes Simplex Virus 28%
• Transgene 28%
• Epithelial Cell Line 14%
• Tumor Volume 14%
• Stromal Cell Line 14%
• Growth Stimulation 14%
• Transgenics 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Tumor Model 100%
• Neoplasm 100%
• Mouse 36%
• Cancer Growth 27%
• Prostate Specific Antigen 27%
• Prostate Tumor 27%
• Osteocalcin 27%
• Tumor Growth 18%
• Osteosarcoma 18%
• Herpes Simplex Virus 18%
• Thymidine Kinase 18%
• Ganciclovir 18%
• Cancer Model 9%
• Malignant Neoplasm 9%
• Cell Protein 9%
• Bone Metastasis 9%
• Prodrug 9%
• Aciclovir 9%
• Distant Metastasis 9%
• N (4 Methoxyphenylacetyl)dehydroalanine 9%
• Androgen 9%
• Luciferase 9%